NFκB is a pleiotropic transcription factor capable of activating the expression of a great variety of genes critical for the immunoinflammatory response. Tumor necrosis factor α (TNFα) and lymphotoxin α (LTα, originally TNFβ) are potent nuclear factor κB (NFκB) activators in various cell types. The LTα molecule, in addition to being secreted as a soluble trimer, can also form membrane-anchored heterotrimers with the LTβ chain, another member of the TNF family. The LTα1β2 heterotrimer binds a specific receptor, called the LTβ receptor (LTβ-R), which is also a member of the TNF receptor family. Here, we show that engagement of LTβ-R with a soluble form of LTα1β2 or with a specific anti-LTβ-R agonistic monoclonal antibody CBE11 quickly induces activation of NFκB in HT-29 and WiDr human adenocarcinomas. LTβ-R triggering activates NFκB and induces proliferation in WI-38 human lung fibroblasts. No NFκB activation is observed in human umbilical vein endothelial cells, correlating with the inability of LTβ-R activation to induce expression of NFκB-dependent cell surface adhesion molecules. Thus, like several other members of the TNF receptor family, the LTβ-R can activate NFκB following receptor ligation in some but not all LTβ-R-positive cells.
The costs of publication of this article were defrayed in part by the payment of page charges. The article must therefore be hereby marked “advertisement” in accordance with 18 U.S.C. Section 1734 solely to indicate this fact.